Readers of this blog are, by now, aware of the many issues surrounding Merck’s blockbuster nonsteroidal, anti-inflammatory medication Vioxx (rofecoxib) and negative cardiac events. The cardiac problems associated with Vioxx, and its subsequent withdrawal from the market, spawned scores of lawsuits. These include Merck shareholder lawsuits, which were recently the subject of oral [ ]
Vioxx Claimants Signing Up at the Wire
With tens of thousands of Vioxx claimants tentatively signed on to a $4.85 billion settlement and more claims pouring in just under the wire Tuesday, their lawyers and drug maker Merck & Co. predicted the deal will proceed.
NEW ORLEANS -- People who think their heart attacks or strokes were caused by the once-popular painkiller Vioxx and want early partial payments now have another month to file paperwork Read more here
Contact:
Copyright © 2005 Vioxx Advisor.com All Rights Reserved